WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2000063205) THIAZOLIDINEDIONE DERIVATIVE AND ITS USE AS ANTIDIABETIC
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2000/063205    International Application No.:    PCT/GB2000/001521
Publication Date: 26.10.2000 International Filing Date: 19.04.2000
Chapter 2 Demand Filed:    14.11.2000    
IPC:
C07D 417/12 (2006.01)
Applicants: SMITHKLINE BEECHAM P.L.C. [GB/GB]; New Horizons Court, Brentford, Middlesex TW8 9EP (GB) (For All Designated States Except US).
BLACKLER, Paul, David, James [GB/GB]; (GB) (For US Only).
GILES, Robert, Gordon [GB/GB]; (GB) (For US Only).
SASSE, Michael, John [GB/GB]; (GB) (For US Only)
Inventors: BLACKLER, Paul, David, James; (GB).
GILES, Robert, Gordon; (GB).
SASSE, Michael, John; (GB)
Agent: RUTTER, Keith; SmithKline Beecham, Corporate Intellectual Property, Two New Horizons Court, Brentford, Middlesex TW8 9EP (GB)
Priority Data:
9909041.7 20.04.1999 GB
Title (EN) THIAZOLIDINEDIONE DERIVATIVE AND ITS USE AS ANTIDIABETIC
(FR) NOUVEAU COMPOSE PHARMACEUTIQUE
Abstract: front page image
(EN)5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione, hydrochloride dihydrate characterised in that it: (i) provides an infrared spectrum containing peaks at 3392, 2739, 1751, 1325 and 713 cm?-1¿; and/or (ii) provides an X-ray powder diffraction (XRPD) pattern containing peaks at 9.1, 12.0, 15.7, 16.3 and 19.8 °2$g(u); a process for preparing such a compound, a pharmaceutical composition containing such a compound and the use of such a compound in medicine.
(FR)La présente invention concerne un composé de dihydrate d'hydrochlorure 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione, qui se caractérise en ce qu'il: (i) produit un spectre infrarouge présentant des pics à 3392, 2739, 1751, 1325 et 713 cm?-1¿; et/ou (ii) produit un diagramme de diffraction des rayons X d'une poudre qui contient des pics à 9,1 ; 12,0 ; 15,7 ; 16,3 et 19,8 °2$g(u). On décrit également un procédé de préparation de ce composé, une composition pharmaceutique contenant ledit composé et l'utilisation de ce dernier en médecine.
Designated States: AE, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)